Medtronic plc (MDT) shareholders
Close on Nov 17, 2026Market cap $130.88BP/E 25.1Yield 2.78%
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Vanguard Capital Management | 96,424,044 | 7.51% | 13G (passive) | Mar 31, 2026 |
| BlackRock, Inc. | 88,655,585 | 6.90% | 13G (passive) amendment | Mar 31, 2025 |
| State Street Corporation | 66,055,969 | 5.20% | 13G (passive) | Sep 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of MDT | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 114,020,787 | 8.91% | $8.92B | +838,220 | 0.13% |
| Vanguard Capital Management LLC | 83,816,735 | 6.55% | $6.56B | +482,902 | 0.14% |
| State Street Corp | 63,399,315 | 4.96% | $5.01B | +1,658,301 | 0.15% |
| Vanguard Portfolio Management LLC | 34,059,967 | 2.66% | $2.66B | +609,409 | 0.12% |
| Geode Capital Management, LLC | 30,192,015 | 2.36% | $2.35B | +1,455,674 | 0.13% |
| JPMorgan Chase & Co | 27,784,471 | 2.17% | $2.25B | −23,189,070 | 0.12% |
| First Eagle Investment Management, LLC | 27,567,966 | 2.16% | $2.16B | +17,523,271 | 1.79% |
| Bank Of America Corp /De/ | 21,322,401 | 1.67% | $1.67B | −4,692,602 | 0.11% |
| Massachusetts Financial Services Co /Ma/ | 19,872,600 | 1.55% | $2.61B | −1,564,999 | 0.83% |
| Morgan Stanley | 19,444,871 | 1.52% | $1.52B | −1,272,158 | 0.08% |
| Deutsche Bank AG\ | 18,449,877 | 1.44% | $1.44B | −552,537 | 0.42% |
| Invesco Ltd. | 17,885,150 | 1.40% | $1.40B | +1,098,152 | 0.11% |
| Franklin Resources Inc | 17,550,983 | 1.37% | $1.37B | +3,375,304 | 0.30% |
| Norges Bank | 16,551,016 | 1.29% | $1.29B | New | 0.13% |
| Royal Bank of Canada | 16,026,475 | 1.25% | $1.25B | +1,846,658 | 0.19% |
| Bank of New York Mellon Corp | 14,694,253 | 1.15% | $1.15B | −807,616 | 0.19% |
| Capital Research Global Investors | 13,261,310 | 1.04% | $1.04B | −28,665,280 | 0.14% |
| Arrowstreet Capital, Limited Partnership | 12,892,710 | 1.01% | $1.01B | +8,233,285 | 0.45% |
| Northern Trust Corp | 11,626,741 | 0.91% | $909.56M | −410,080 | 0.11% |
| Ameriprise Financial Inc | 11,565,988 | 0.90% | $904.73M | −413,943 | 0.18% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2,126 | 1.11B | 86.5% | 169 / 848 | 916 / 244 | 143M | 127M |
| Q1 2026 | 2,239 | 1.09B | 85.6% | 185 / 904 | 893 / 211 | 214M | 84M |
| Q4 2025 | 2,306 | 1.10B | 85.8% | 291 / 879 | 880 / 108 | 69M | 95M |
| Q3 2025 | 2,171 | 1.13B | 88.2% | 190 / 917 | 816 / 127 | 123M | 90M |
| Q2 2025 | 2,139 | 1.09B | 85.6% | 147 / 880 | 876 / 147 | 75M | 58M |
| Q1 2025 | 2,167 | 1.08B | 84.4% | 209 / 940 | 799 / 126 | 77M | 61M |
| Q4 2024 | 2,118 | 1.07B | 83.5% | 247 / 787 | 885 / 154 | 80M | 84M |
| Q3 2024 | 2,056 | 1.08B | 84.6% | 180 / 756 | 902 / 116 | 175M | 70M |
| Q2 2024 | 2,016 | 1.09B | 85.2% | 141 / 822 | 835 / 162 | 33M | 121M |
| Q1 2024 | 2,065 | 1.18B | 92.4% | 176 / 929 | 726 / 148 | 90M | 44M |
| Q4 2023 | 2,066 | 1.14B | 89.1% | 272 / 647 | 986 / 135 | 104M | 55M |
| Q3 2023 | 1,959 | 1.09B | 85.4% | 116 / 916 | 732 / 173 | 41M | 36M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
366 funds held MDT in Q2 2026, 65% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of MDT | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 40,757,422 | 3.19% | $3.19B | 0.14% | Jun 30, 2026 |
| Vanguard 500 Index Fund | 33,271,457 | 2.60% | $2.60B | 0.16% | Jun 30, 2026 |
| Vanguard Value Index Fund | 12,221,643 | 0.96% | $956.10M | 0.38% | Jun 30, 2026 |
| Vanguard Dividend Appreciation Index Fund | 7,264,159 | 0.57% | $620.29M | 0.47% | Jul 31, 2026 |
| Vanguard Institutional Index Fund | 6,970,004 | 0.54% | $545.26M | 0.16% | Jun 30, 2026 |
| Dodge & Cox Stock Fund | 5,743,900 | 0.45% | $449.35M | 0.38% | Jun 30, 2026 |
| Vanguard Windsor Ii Fund | 5,314,118 | 0.42% | $453.77M | 0.68% | Jul 31, 2026 |
| Vanguard High Dividend Yield Index Fund | 5,164,324 | 0.40% | $440.98M | 0.44% | Jul 31, 2026 |
| WCM Focused International Growth Fund | 4,354,530 | 0.34% | $340.65M | 1.51% | Jun 30, 2026 |
| Vanguard Health Care Fund | 4,228,128 | 0.33% | $361.04M | 0.95% | Jul 31, 2026 |
| Vanguard Health Care Index Fund | 3,849,568 | 0.30% | $284.14M | 1.50% | May 31, 2026 |
| iShares Russell 1000 Value ETF | 2,864,802 | 0.22% | $224.11M | 0.28% | Jun 30, 2026 |
| Invesco S&P 500 Equal Weight ETF | 2,321,607 | 0.18% | $198.24M | 0.21% | Jul 31, 2026 |
| Invesco Value Opportunities Fund | 2,314,922 | 0.18% | $197.67M | 2.17% | Jul 31, 2026 |
| Equity Income Fund | 1,925,722 | 0.15% | $150.65M | 2.33% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Geoffrey Martha | Chairman and CEO, Director | 277,866 | 0.02% | Oct 16, 2026 |
| Michael Marinaro | President | 113,353 | 0.01% | Nov 4, 2026 |
| Harry Skip Kiil | EVP & President Cardiovascular | 42,186 | 0.00% | Sep 17, 2026 |
| Denise L. Blomquist | Chief Accounting Officer | 16,398 | 0.00% | Sep 16, 2026 |
| Kweli Thompson | EVP & President, Neuroscience | 35,390 | 0.00% | Aug 4, 2026 |
| Michelle Quinn | EVP, GC and Secretary | 26,721 | 0.00% | Aug 4, 2026 |
| Matthew R. Walter | SVP, Chief HR Officer | 39,928 | 0.00% | Aug 4, 2026 |
| Thierry Pieton | EVP & Chief Financial Officer | 49,645 | 0.00% | Aug 4, 2026 |
| Brett A. Wall | EVP & Pres Neuroscience | 82,183 | 0.01% | May 28, 2026 |
| Gregory L. Smith | EVP Global Ops & Supply Chain | 51,830 | 0.00% | Nov 21, 2025 |
| Gary Louis Corona | Interim CFO | 44,255 | 0.00% | Jan 23, 2025 |
| Ivan K. Fong | EVP GENERAL COUNSEL & SECR | 54,692 | 0.00% | Dec 17, 2024 |
| Sean Salmon | EVP & President Cardiovascular | 64,722 | 0.01% | Dec 17, 2024 |
| Jennifer M. Kirk | Chief Accounting Officer | 28,011 | 0.00% | Dec 10, 2024 |
| Kevin E. Lofton | Director | 9,977 | 0.00% | Oct 21, 2026 |
| Joon Sup Lee | Director | 1,803 | 0.00% | Apr 29, 2026 |
| Craig Arnold | Director | 42,185 | 0.00% | Apr 29, 2026 |
| William R. Jellison | Director | 6,444 | 0.00% | Apr 29, 2026 |
| Scott C. Donnelly | Director | 23,924 | 0.00% | Apr 29, 2026 |
| Randall J. Hogan | Director | 86,082 | 0.01% | Apr 29, 2026 |
| Kendall J. Powell | Director | 54,380 | 0.00% | Apr 29, 2026 |
| Lidia Fonseca | Director | 7,644 | 0.00% | Apr 29, 2026 |
| Elizabeth G. Nabel | Director | 19,584 | 0.00% | Apr 29, 2026 |
| John P. Groetelaars | Director | 1,444 | 0.00% | Apr 29, 2026 |
| Gregory P. Lewis | Director | 5,754 | 0.00% | Apr 29, 2026 |
| Andrea Jo Goldsmith | Director | 10,247 | 0.00% | Apr 30, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Michael Marinaro President | Nov 2, 2026 | Award | +6,547 | – | – | 113,353 |
| Kevin E. Lofton Director | Oct 15, 2026 | Other | −182 | – | – | 9,977 |
| Michael Marinaro EVP, Pres MedSurg and Americas | Oct 15, 2026 | Sale(10b5-1 plan) | −10,420 | $96.00 | $1.00M | 105,916 |
| Geoffrey Martha Chairman and CEO, Director | Oct 15, 2026 | Sale(10b5-1 plan) | −50,000 | $95.00 | $4.75M | 277,866 |
| Harry Skip Kiil EVP & President Cardiovascular | Sep 16, 2026 | Sale | −1,483 | $93.65 | $138.88K | 42,186 |
| Denise L. Blomquist Chief Accounting Officer | Sep 15, 2026 | Gift | −600 | – | – | 16,398 |
| Michael Marinaro EVP, Pres MedSurg and Americas | Aug 20, 2026 | Tax withholding | −1,084 | $92.30 | $100.05K | 116,336 |
| Denise L. Blomquist Chief Accounting Officer | Aug 3, 2026 | Award | +2,337 | – | – | 16,998 |
| Michael Marinaro EVP, Pres MedSurg and Americas | Aug 3, 2026 | Award | +10,960 | – | – | 71,273 |
| Michael Marinaro EVP, Pres MedSurg and Americas | Aug 3, 2026 | Award | +46,147 | – | – | 117,420 |
| Thierry Pieton EVP & Chief Financial Officer | Aug 3, 2026 | Award | +11,537 | – | – | 49,645 |
| Michelle Quinn EVP, GC and Secretary | Aug 3, 2026 | Award | +6,346 | – | – | 26,721 |
| Harry Skip Kiil EVP & President Cardiovascular | Aug 3, 2026 | Award | +9,230 | – | – | 43,669 |
| Matthew R. Walter SVP, Chief HR Officer | Aug 3, 2026 | Award | +5,769 | – | – | 39,928 |
| Geoffrey Martha Chairman and CEO, Director | Aug 3, 2026 | Award | +41,533 | – | – | 327,866 |
| Kweli Thompson EVP & President, Neuroscience | Aug 3, 2026 | Award | +6,923 | – | – | 35,390 |
| Denise L. Blomquist Chief Accounting Officer | Jul 31, 2026 | Tax withholding | −212 | $85.39 | $18.10K | 14,661 |
| Michael Marinaro EVP, Pres MedSurg and Americas | Jul 31, 2026 | Tax withholding | −3,356 | $85.39 | $286.57K | 60,313 |
| Harry Skip Kiil EVP & President Cardiovascular | Jul 31, 2026 | Tax withholding | −3,074 | $85.39 | $262.49K | 34,439 |
| Matthew R. Walter SVP, Chief HR Officer | Jul 31, 2026 | Tax withholding | −1,675 | $85.39 | $143.03K | 34,159 |
| Geoffrey Martha Chairman and CEO, Director | Jul 31, 2026 | Tax withholding | −15,810 | $85.39 | $1.35M | 286,333 |
| Kweli Thompson EVP & President, Neuroscience | Jul 31, 2026 | Tax withholding | −1,739 | $85.39 | $148.49K | 28,467 |
| Michelle Quinn EVP, GC and Secretary | Jul 28, 2026 | Tax withholding | −2,069 | $86.88 | $179.75K | 20,375 |
| Matthew R. Walter SVP, Chief HR Officer | Jul 8, 2026 | Sale(10b5-1 plan) | −3,102 | $83.15 | $257.93K | 35,694 |
| Harry Skip Kiil EVP & President Cardiovascular | Jun 8, 2026 | Sale | −3,961 | $80.44 | $318.62K | 37,455 |
| Harry Skip Kiil EVP & President Cardiovascular | Jun 8, 2026 | Sale | −228 | $80.45 | $18.34K | 37,227 |
| Denise L. Blomquist Chief Accounting Officer | Jun 5, 2026 | Tax withholding | −237 | $83.32 | $19.75K | 14,737 |
| Michael Marinaro EVP, Pres MedSurg and Americas | Jun 4, 2026 | Tax withholding | −7,471 | $83.32 | $622.48K | 63,122 |
| Geoffrey Martha Chairman and CEO, Director | Jun 4, 2026 | Tax withholding | −41,936 | $83.32 | $3.49M | 301,163 |
| Harry Skip Kiil EVP & President Cardiovascular | Jun 4, 2026 | Tax withholding | −6,817 | $83.32 | $567.99K | 41,416 |
| Matthew R. Walter SVP, Chief HR Officer | Jun 4, 2026 | Tax withholding | −2,840 | $83.32 | $236.63K | 38,689 |
| Denise L. Blomquist Chief Accounting Officer | May 26, 2026 | Option exercise | +1,712 | – | – | 14,974 |
| Michael Marinaro EVP, Pres MedSurg and Americas | May 26, 2026 | Option exercise | +18,994 | – | – | 70,593 |
| Geoffrey Martha Chairman and CEO, Director | May 26, 2026 | Option exercise | +94,963 | – | – | 343,099 |
| Brett A. Wall EVP & Pres Neuroscience | May 26, 2026 | Option exercise | +26,907 | – | – | 82,183 |
| Harry Skip Kiil EVP & President Cardiovascular | May 26, 2026 | Option exercise | +15,195 | – | – | 48,233 |
| Matthew R. Walter SVP, Chief HR Officer | May 26, 2026 | Option exercise | +9,149 | – | – | 41,529 |
| Matthew R. Walter SVP, Chief HR Officer | May 1, 2026 | Tax withholding | −35 | $80.00 | $2.80K | 32,380 |
| Lidia Fonseca Director | Apr 28, 2026 | Tax withholding | −207 | $81.90 | $16.95K | 7,644 |
| Gregory P. Lewis Director | Apr 28, 2026 | Tax withholding | −207 | $81.90 | $16.95K | 5,754 |
| Kendall J. Powell Director | Apr 28, 2026 | Tax withholding | −207 | $81.90 | $16.95K | 51,380 |
| Kevin E. Lofton Director | Apr 28, 2026 | Tax withholding | −207 | $81.90 | $16.95K | 10,140 |
| Elizabeth G. Nabel Director | Apr 28, 2026 | Tax withholding | −207 | $81.90 | $16.95K | 19,584 |
| Randall J. Hogan Director | Apr 28, 2026 | Tax withholding | −207 | $81.90 | $16.95K | 48,998 |
| Denise L. Blomquist Chief Accounting Officer | Apr 28, 2026 | Tax withholding | −318 | $81.90 | $26.04K | 13,262 |
| Craig Arnold Director | Apr 28, 2026 | Tax withholding | −207 | $81.90 | $16.95K | 42,185 |
| Scott C. Donnelly Director | Apr 28, 2026 | Tax withholding | −207 | $81.90 | $16.95K | 23,679 |
| Lidia Fonseca Director | Apr 27, 2026 | Award | +2,111 | – | – | 7,851 |
| William R. Jellison Director | Apr 27, 2026 | Award | +1,444 | – | – | 6,444 |
| Gregory P. Lewis Director | Apr 27, 2026 | Award | +2,111 | – | – | 5,961 |
| Kendall J. Powell Director | Apr 27, 2026 | Award | +2,111 | – | – | 51,587 |
| Kevin E. Lofton Director | Apr 27, 2026 | Award | +2,111 | – | – | 10,347 |
| Elizabeth G. Nabel Director | Apr 27, 2026 | Award | +2,111 | – | – | 19,791 |
| Randall J. Hogan Director | Apr 27, 2026 | Award | +2,111 | – | – | 49,205 |
| Denise L. Blomquist Chief Accounting Officer | Apr 27, 2026 | Award | +1,508 | – | – | 13,580 |
| Craig Arnold Director | Apr 27, 2026 | Award | +2,111 | – | – | 42,392 |
| Joon Sup Lee Director | Apr 27, 2026 | Award | +1,803 | – | – | 1,803 |
| Scott C. Donnelly Director | Apr 27, 2026 | Award | +2,111 | – | – | 23,886 |
| John P. Groetelaars Director | Apr 27, 2026 | Award | +1,444 | – | – | 1,444 |
| Thierry Pieton EVP & Chief Financial Officer | Mar 3, 2026 | Tax withholding | −2,976 | $96.71 | $287.81K | 37,574 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Medtronic's stock actually held short. Settlement fails (shares not delivered on time) peaked at 133,982 shares on Oct 5, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Geoffrey Martha Officer, Director | Oct 15, 2026 | 50,000 | $4.75M | Oct 15, 2026 | Restricted Stock Vesting |
| Michael Marinaro Officer | Oct 15, 2026 | 10,420 | $1.00M | Oct 15, 2026 | ESPP Purchase |
| Harry Skip Kiil Officer | Sep 16, 2026 | 1,483 | $138.89K | Sep 16, 2026 | Restricted Stock Vesting |
| Matthew R. Walter Officer | Jul 8, 2026 | 3,102 | $257.93K | Jul 8, 2026 | ESPP Purchase |
| Harry Skip Kiil Officer | Jun 8, 2026 | 4,189 | $336.97K | Jun 8, 2026 | Restricted Stock Vesting |
| Harry Skip Kiil Officer | Feb 19, 2026 | 52,524 | $5.13M | Feb 19, 2026 | Restricted Stock Vesting |
| Gregory L. Smith Officer | Nov 19, 2025 | 30,000 | $3.06M | Nov 19, 2025 | ESPP Purchase |
| Harry Skip Kiil Officer | Sep 3, 2025 | 8,605 | $788.05K | Sep 3, 2025 | Restricted Stock Vesting |
| Sean Salmon Officer | Jun 6, 2025 | 18,378 | $1.60M | Jun 6, 2025 | Option Granted 08/03/2015 |
| Brett A. Wall Officer | Jan 24, 2025 | 12,437 | $1.12M | Jan 24, 2025 | Options Granted 08/03/2015 |
| Brett A. Wall Officer | Jan 8, 2025 | 9,850 | $792.04K | Jan 8, 2025 | Stock Option Exercise |
| Karen L. Parkhill Former Director | Oct 31, 2024 | 30,000 | $2.69M | Oct 31, 2024 | Option Granted- 07/30/2018 |
| Karen L. Parkhill Former Director | Oct 30, 2024 | 15,000 | $1.36M | Oct 30, 2024 | Option Granted- 07/30/2018 |
| Karen L. Parkhill Former BOD | Oct 29, 2024 | 15,000 | $1.37M | Oct 29, 2024 | Option Granted - 07/30/2018 |
| Karen L. Parkhill Former Director | Oct 24, 2024 | 22,712 | $2.10M | Oct 24, 2024 | Options Granted 08/01/2016 |
Congress trades
40 trades in Medtronic reported by 17 members of the House
| Member | Type | Traded | Amount | Filed |
|---|---|---|---|---|
| Kevin Hern OK01 · joint account | Sold | Aug 24, 2026 | $15K–50K | Sep 1, 2026 |
| Richard Dean Dr McCormick GA06 | Sold | Jul 30, 2026 | $1K–15K | Aug 14, 2026 |
| Gilbert Cisneros CA31 | Sold (part) | May 15, 2026 | $1K–15K | Jun 8, 2026 |
| Kevin Hern OK01 · joint account | Sold | Mar 20, 2026 | $15K–50K | Apr 3, 2026 |
| Julie Johnson TX32 · joint account | Sold | Dec 18, 2025 | $1K–15K | Jan 15, 2026 |
| Julie Johnson TX32 · joint account | Sold (part) | Nov 13, 2025 | $1K–15K | Dec 11, 2025 |
| Richard Dean Dr McCormick GA06 | Bought | Nov 5, 2025 | $1K–15K | Dec 9, 2025 |
| Julie Johnson TX32 · joint account | Sold (part) | Aug 14, 2025 | $1K–15K | Sep 11, 2025 |
| Rob Bresnahan PA08 | Bought | May 15, 2025 | $1K–15K | May 31, 2025 |
| Jefferson Shreve IN06 | Sold | May 8, 2025 | $15K–50K | Jun 22, 2025 |
| Julie Johnson TX32 · joint account | Sold (part) | May 7, 2025 | $1K–15K | Aug 5, 2026 455 days late |
| Rob Bresnahan PA08 | Sold | Apr 8, 2025 | $1K–15K | Apr 28, 2025 |
| George Whitesides CA27 | Sold | Mar 24, 2025 | $50K–100K | Apr 23, 2025 |
| Bruce Westerman AR04 | Sold | Mar 20, 2025 | $1K–15K | Apr 16, 2025 |
| Bruce Westerman AR04 | Bought | Mar 4, 2025 | $1K–15K | Apr 16, 2025 |
| Rob Bresnahan PA08 | Bought | Feb 25, 2025 | $1K–15K | Mar 27, 2025 |
| Emily Randall WA06 · spouse | Sold | Jan 6, 2025 | $1K–15K | Feb 11, 2025 |
| John James MI10 | Sold | Sep 4, 2024 | $1K–15K | Sep 6, 2024 |
| Earl Blumenauer OR03 · spouse | Sold | Jul 9, 2024 | $1K–15K | Aug 6, 2024 |
| Kathy Manning NC06 · spouse | Sold (part) | Jul 2, 2024 | $1K–15K | Aug 16, 2024 |
| John James MI10 | Bought | Jun 18, 2024 | $1K–15K | Sep 2, 2024 76 days late |
| John James MI10 | Sold (part) | Jun 3, 2024 | $1K–15K | Sep 2, 2024 91 days late |
| Kathy Manning NC06 · spouse | Bought | Jan 23, 2024 | $1K–15K | Feb 6, 2024 |
| Kathy Manning NC06 · spouse | Bought | Jan 23, 2024 | $15K–50K | Feb 6, 2024 |
| Kathy Manning NC06 · spouse | Bought | Jan 23, 2024 | $1K–15K | Feb 6, 2024 |
| Jared Moskowitz FL23 | Sold | Dec 28, 2023 | $1K–15K | Aug 21, 2024 237 days late |
| Jared Moskowitz FL23 · child | Sold | Dec 28, 2023 | $1K–15K | Jan 22, 2024 |
| Jared Moskowitz FL23 · child | Sold | Dec 28, 2023 | $1K–15K | Jan 22, 2024 |
| Kathy Manning NC06 · spouse | Sold | Dec 12, 2023 | $1K–15K | Jan 12, 2024 |
| Kathy Manning NC06 · spouse | Sold | Dec 12, 2023 | $15K–50K | Jan 12, 2024 |
| Kathy Manning NC06 · spouse | Sold | Dec 12, 2023 | $1K–15K | Jan 12, 2024 |
| Debbie Dingell MI06 | Bought | Dec 5, 2023 | $15K–50K | Dec 14, 2023 |
| John James MI10 | Bought | Nov 10, 2023 | $1K–15K | Sep 2, 2024 297 days late |
| Greg Stanton AZ04 · spouse | Sold | Oct 24, 2023 | $1K–15K | Nov 9, 2023 |
| Greg Stanton AZ04 · spouse | Bought | Sep 26, 2023 | $1K–15K | Nov 9, 2023 |
| Michael Patrick Guest MS03 · spouse | Bought | Aug 7, 2023 | $1K–15K | Aug 23, 2023 |
| Pete Sessions TX17 · spouse | Sold | Jun 15, 2023 | $15K–50K | Jun 26, 2023 |
| Kathy Manning NC06 · spouse | Bought | Apr 28, 2023 | $1K–15K | May 19, 2023 |
| Kathy Manning NC06 | Bought | Apr 28, 2023 | $1K–15K | May 19, 2023 |
| Richard Dean Dr McCormick GA06 | Bought | Mar 15, 2023 | $1K–15K | Sep 17, 2025 917 days late |
See a number that looks wrong?